inmnulógico for the formulation of vaccines against Leishmaniasis vaccine adjuvant understands

摘要

The invention relates to the use of compounds comprising a molecule of lipid origin and a vinyl sulfone group as an immunological adjuvant. The lipid molecule binds to an antigen in order to form a lipopeptide that acts as a vaccine. The invention also relates to an immunnoadjuvant comprising said compounds, to a vaccine comprising said lipopeptides, i.e. the compound of the invention used as an immunoadjuvant and an antigen, and specifically to the abovementioned Leishmaniasis vaccine.